Introduction to ESMO 2025 Genitourinary Cancer Abstracts ESMO 2025 genitourinary cancer abstracts show exciting new finds. For instance, they include a 78% rPFS boost in prostate studies. In addition, these works cover prostate, bladder, and kidney cancers. Experts ranked them by impact, trial stage, new ideas, and care changes. Moreover, the list comes from @OncoAlert. … Continue reading ESMO 2025 Top 10 Genitourinary Cancer Must-See Abstracts: 78% rPFS Boost Unveiled